Results 81 to 90 of about 37,942 (184)
Mortality of Invasive Pneumococcal Disease following Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Greenland [PDF]
Kristiana Alexandrova Nikolova +3 more
openalex +1 more source
Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against Pneumococcal Diseases Among the Elderly Aged 60 Years or Older: A Matched Test Negative Case-Control Study in Shanghai, China [PDF]
Xiaodong Sun +13 more
openalex +1 more source
Approaches to vaccination of adults against pneumococcal disease in different countries of the world
Various pneumococcal vaccines are available worldwide, differing in the range of serotypes coverage and type of vaccine, which determine different mechanisms of action and postvaccinal immunity. Vaccination against pneumococcal infection is recommended
A. S. Korovkin +2 more
doaj +1 more source
Multivalent pneumococcal vaccines have been developed successfully to combat invasive pneumococcal diseases (IPD) and reduce the associated healthcare burden.
James Z. Deng +10 more
doaj +1 more source
Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: results from a long-term extension trial substudy [PDF]
Kevin Winthrop +6 more
openalex +1 more source
PNEUMOCOCCAL INFECTION. NEW OPPORTUNITIES IN VACCINOPROPHYLAXIS OF PNEUMOCOCCAL INFECTION
Pneumococcal infection is the most frequent cause of diseases of upper and inferior airways and nasopharynx in children. Also pneumococcal infection may cause such severe diseases as meningitis and pneumonia. The only way of prophylaxis of these diseases
M.G. Galitskaya +2 more
doaj
Limited data from Asia are available on long-term effects of pneumococcal conjugate vaccine introduction on pneumococcal carriage. Here we assess the impact of 13-valent pneumococcal conjugate vaccine (PCV13) introduction on nasopharyngeal pneumococcal ...
Claire von Mollendorf +19 more
doaj +1 more source

